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Abstract
Background: Sleep-disordered breathing (SDB), especially obstructive sleep apnea (OSA), has frequent complications
include hypertension, dyslipidemia and insulin resistance based on abdominal obesity or excess visceral fat (called
Syndrome Z). OSA is a potential risk factor for cardiovascular diseases. The clinical characteristics of Japanese OSA
subjects with OSA remain unclear. The present study investigated prevalence and predictive factors of intracoronary
stenosis detected by multislice computed tomography (MSCT) in Japanese male subjects with SDB/OSA.
Findings: The study (O-VFStudy) subjects were 39 Japanese men with SDB/OSA who underwent all-night
cardiorespiratory monitoring with fully attended polysomnography, and moreover both fat computed tomography
(CT) scan and 64-row MSCT coronary angiography. The prevalence of coronary stenosis in this selected population
with SDB/OSA was 15%. Logistic regression analysis showed a significant relationship between age-adjusted CAD
and metabolic syndrome (p < 0.05), but not serum adiponectin levels and nocturnal fall in adiponectin. Subjects
with the metabolic syndrome had significantly higher prevalence of CAD (31.3 versus 4.3%, p = 0.033), and lower
levels of serum adiponectin (4.5 ± 0.6 versus 6.4 ± 0.6 μg/mL, p = 0.014), compared with groups without the
metabolic syndrome.
Conclusions: The present study describes that the prevalence of greater than 50% intracoronary stenotic lesions
detected by MSCT was 15% and the metabolic syndrome was correlated with intracoronary stenosis detected by
MSCT in Japanese SDB/OSA subjects.
Trial Registration: UMIN 000002997
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?
function=brows&action=brows&type=summary&recptno=R000003633&language=E.
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Background
Sleep-disordered breathing (SDB), especially obstructive
sleep apnea (OSA), is a potential risk factor for cardio-
vascular diseases, including coronary artery disease
(CAD) and stroke [1-3]. OSA is common in middle-age
men [4], and frequent complications include
hypertension, dyslipidemia and insulin resistance based
on abdominal obesity or excess visceral fat [5-8]. Visc-
eral fat is a huge endocrine organ producing a variety of
bioactive substances, conceptualized as ‘adipocytokines’
[9]. Our group discovered adiponectin as an adipocyto-
kine in the human adipose cDNA library [10], which
has anti-atherosclerotic property [11]. We have recently
demonstrated that, 1) production of adiponectin is dys-
regulated in intra-abdominal obese patients with severe
OSA [12,13], and 2) night-time onset of acute coronary
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[14], which is called “Syndrome Z” [15]. However, there
is little information on clinical features of Japanese OSA
subjects with CAD.
The present study investigated prevalence and predic-
tive factors of intracoronary stenosis detected by multi-
slice computed tomography (MSCT) in Japanese male
subjects with OSA.
Methods and procedures
Participants
Subjects were recruited from 50 consecutive Japanese
male subjects with a history of snoring and/or witnessed
apneas, who underwent all-night cardiorespiratory mon-
itoring in the Yoshida Suimin-kokyu Clinic (Osaka,
Japan) and had no history of CAD, which was defined
as documentation of medication and history of myocar-
dial infarction, angina, and/or previous coronary inter-
vention. The study (O-VFStudy) subjects comprised 39
Japanese, who moreover underwent both fat computed
tomography (CT) scan and 64-row MSCT coronary
angiography (GE-LightSpeed VCT) in Kenporen Osaka
Central Hospital (Osaka, Japan), excluding subjects with
contrast-allergic disease and/or renal dysfunction (serum
creatinine > 1.5 mg/dL) (n = 6), and apnea hypopnea
index (AHI) < 5 events/hour (n = 5). The study was
approved by the human ethics committee of each parti-
cipating hospital and informed consent was obtained
from each participant.
Cardiorespiratory monitoring
All participants underwent overnight cardiorespiratory
monitoring with fully attended polysomnography
(Alice
®4 Diagnostics Sleep System, Philips Respironics).
The recorded signals were analyzed for the number of
apneas and hypopneas. Apnea represented a decrease in
the amplitude of airflow signal or thoracoabdominal
motion decreased to < 10% of the baseline for at least
10 seconds. Hypopnea was defined as a decrease in air-
flow or respiratory effort to < 70% of baseline for at
least 10 seconds associated with > 4% desaturation but
did not meet the criteria for an apnea. The AHI was
defined as the total number of apneas/hypopneas per
hour of sleep time [16,17]. An AHI ≥ 5 established the
diagnosis of SDB. All recordings were scored manually
by an experienced polysomnographic technologist. The
Epworth Sleepiness Scale (ESS) was used to report sub-
jective day-time sleepiness [18]. Excessive daytime slee-
piness was defined as an ESS score greater than 10.
CT images
Total fat area, visceral fat area and subcutaneous fat
area were computed and measured automatically using
commercial software on CT scans taken at the umbilical
level in a supine position (120 kV, 400 mAsec, section
thickness of 5-10 mm, field of view of 400 mm, window
width of 800-1000 Hounsfield units). All MSCT angio-
grams were scanned by trained technicians, according to
a standard protocol. All MSCT angiograms were evalu-
ated by at least two experienced examiners. The pre-
sence of stenosis with coronary plaque was evaluated
visually on axial and cross-sectional images and curved
multiplanar reconstructions. Intracoronary lesion was
identified as atherosclerotic stenosis and/or highly calci-
fication lesion of at least one segment of a major coron-
ary artery confirmed by MSCT coronary angiograms,
w h i c hi sg r e a t e rt h a n5 0 %s t e n o s i sa sac a n d i d a t ef o r
revascularization [19,20]. Patients with intracoronary
lesion were considered to have CAD.
Anthropometry and laboratory measurements
H e i g h t( c m ) ,w e i g h t( k g )( a n db o d ym a s si n d e xi nk g /
m
2), neck circumference at the level of the cricothyroid
cartilage, waist circumference at the umbilical level and
hip circumference horizontally at the level of the greater
trochanter of the femur, were measured in the standing
position. Systolic and diastolic blood pressures were
measured with a standard mercury sphygmomanometer
on the right or left arm after the subjects had rested in
a sitting position for at least 10 minutes. Smoking habit
was documented on the routine baseline questionnaire.
Metabolic syndrome was defined according to the Japa-
nese criteria [21].
Venous blood samples were collected in the morning
after overnight fast for measurements of glucose, lipids,
and immunoreactive insulin. In each sleep study that
included high-sensitivity C-reactive protein (hsCRP) and
adiponectin monitoring, venous blood samples were
obtained after wake-up while the subject was in the
supine position. For the purpose of the present study,
serum samples that were obtained at baseline from each
study participant and stored at -20°C, were thawed and
mesured for serum hsCRP (N-Latex CRP II, Dade Behr-
i n gI n c ,M a r b u r g ,G e r m a n y ,i n t ra-coefficients of varia-
tion (CV); 2.0%, inter-CV 2.3%) and adiponectin
concentrations (Otsuka Pharmaceutical Co., Tokushima,
Japan, intra-CV; 3.0%, inter-CV 5.1%) [12-14,22]. Serum
concentration of thiobarbituric acid-reacting substance
(TBARS), an important biomarker of systemic oxidative
stress reflecting serum lipid peroxidation products, was
determined by the method of Yagi (Japan Institute for
the Control of Aging, Nikken SEIL Co., Shizuoka,
Japan), as reported previously by our group [14,22].
Statistical analysis
The correlations between CAD and clinical features
were first analyzed by simple logistic regression analysis.
In all cases, p values < 0.05 were considered statistically
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Statistical Discovery Software 9.0 (SAS Institute, Cary,
NC).
Results
Characteristics of male subjects with SDB/OSA
Of consecutive 50 subjects with suspected sleep apnea,
data from 39 subjects (mean AHI 39 ± 4 events/h) were
studied. The baseline characteristics of 39 subjects are
listed in Table 1. The percentage of patients with exces-
sive daytime sleepiness (ESS > 10) was 64% (n = 25/39).
Only 15% (n = 6/39) of the subjects showed greater
than 50% intracoronary stenotic lesions detected by
MSCT. Furthermore, the affected coronary artery was
the left anterior descending artery (5 lesions), left cir-
cumflex artery (1 lesion) and right coronary artery (4
lesions), double-vessel disease was identified in 67% (sin-
gle/double/triple = 2/4/0), and 41% of the subjects (n =
16/39) had the metabolic syndrome based on visceral fat
accumulation. Four subjects with CAD (n = 4/6) under-
went successful revascularization with percutaneous cor-
onary intervention procedures, but not coronary artery
bypass graft surgery, and the other two subjects had
taken medications only.
Relationship between CAD and various parameters
Logistic regression analysis was performed to evaluate
the relation between CAD and each parameter listed in
Table 2. Simple logistic regression analysis showed a sig-
nificant relationship between age-adjusted CAD and
metabolic syndrome as well as TBARS (p <0 . 0 5 ) ,b u t
not adiponectin.
Table 1 Baseline characteristics of the subjects (males, n = 39)
mean ± SEM (%) range
Age (years) 52 ± 1 (35-74)
Body mass index (kg/m
2) 27.8 ± 0.6 (20.2-40.3)
Neck circumference (cm) 40 ± 0.4 (36-46)
Waist circumference (cm) 95 ± 1 (80-114)
Hip circumference (cm) 100 ± 1 (90-116)
Total fat area (cm
2) 330 ± 35 (86-1313)
Visceral fat area (cm
2) 163 ± 31 (22-1117)
Subcutaneous fat area (cm
2) 167 ± 9 (64-312)
Smoking (none-/ex-/current-smoker) 13/14/12
Systolic blood pressure (mmHg) 131 ± 2 (100-160)
Diastolic blood pressure (mmHg) 82 ± 2 (58-108)
Fasting blood glucose (mg/dL) 80 ± 3 (61-124)
Fasting immunoreactive insulin (μIU/mL) 11 ± 1 (3-26)
Triglyceride (mg/dL) 158 ± 12 (52-375)
High-density lipoprotein-cholesterol (mg/dL) 49 ± 2 (33-100)
Low-density lipoprotein-cholesterol (mg/dL) 133 ± 3 (97-171)
Diabetes mellitus/Hypertension/Dyslipidemia 3/28/28
Metabolic syndrome 16 (41)
Epworth Sleepiness Scale 13 ± 1 (2-23)
Cardiorespiratory monitoring findings
Apnea-hypopnea index (AHI) (events/hour) 39 ± 4 (8.2-116.6)
Baseline SpO2 (%) 98 ± 0.1 (97-100)
Lowest SpO2 (%) 72 ± 2 (33-91)
4% oxygen desaturation index (events/hour) 27 ± 3 (1.4-91.1)
% < 90% time 7 ± 2 (0-51.4)
Apnea-hypopnea index (AHI) ≥ 5 to < 15 (mild) 7
≥ 15 to < 30 (moderate) 11
≥ 30 (severe) 21
Computed tomography scan findings
< 50% stenosis of coronary arteries 33 (75)
≥ 50% stenosis of coronary arteries 6 (15)
Serum high-sensitive C-reactive protein (hsCRP) (ng/dL) 2131 ± 830 (96-29100)
Serum thiobarbituric acid reactive substance (TBARS), nmol/mL 5.5 ± 0.2 (2.7-8.0)
Serum adiponectin (μg/mL) 5.6 ± 0.5 (2.1-11.8)
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the metabolic syndrome
Subjects with SDB/OSA were divided into two groups
based on the metabolic syndrome [21]. The metabolic
syndrome group had significantly higher prevalence of
CAD and lower levels of serum adiponectin, compared
with groups without the metabolic syndrome (Figure 1;
31.3 versus 4.3%, p = 0.033, 4.5 ± 0.6 versus 6.4 ± 0.6
μg/mL, p = 0.014). There was no significant difference
of AHI and TBARS in two groups (Figure 1; 32.6 ± 5.8
versus 42.7 ± 5.7 events/hour, p = 0.170; 5.2 ± 0.3 ver-
sus 6.0 ± 0.4 nmol/mL, p = 0.094).
Discussion
The two major findings of the present study of SDB/
OSA subjects with a history of snoring and/or witnessed
apneas were: 1) Identification of greater than 50% intra-
coronary narrowing in 15% (6/39) of total, and in 4.3%
(1/23) of subjects without the metabolic syndrome and
in 31.3% (5/16) of those with the metabolic syndrome.
Differences in the above rates were significant (p =
0.033). 2) The metabolic syndrome as well as systemic
oxidative stress, i.e. TBARS, correlated with intracoron-
ary stenosis detected by MSCT. However, multiple logis-
tic regression analysis (adopted factors; age, metabolic
syndrome, TBARS), did not identify both metabolic syn-
drome and TBARS as significant and independent deter-
minants of CAD (p = 0.366, p = 0.062, respectively). The
study included a limited number of patients and further
replication studies of larger sample need to be designed
in the future. Our results may provide a rationale to
conduct such studies.
Although SDB/OSA is associated with cardiovascular
diseases [1-3], there is little information on SDB/OSA
Table 2 Results of simple logistic analysis for coronary
artery disease (CAD)
Model 1 Model 2
Parameter p value p value
Age 0.079 -
Body mass index 0.538 0.329
Neck circumference 0.224 0.164
Waist circumference 0.196 0.134
Hip circumference 0.477 0.365
Log-Total fat area* 0.871 0.414
Log-Visceral fat area* 0.555 0.239
Log-Subcutaneous fat area* 0.671 0.905
Smoking (Ex+current-smoker) 1.000 0.965
Systolic blood pressure 0.631 0.868
Diastolic blood pressure 0.870 0.457
Fasting blood glucose 0.052 0.275
Fasting immunoreactive insulin 0.824 0.671
Log-Triglyceride* 0.702 0.734
High-density lipoprotein-cholesterol 0.354 0.298
Low-density lipoprotein-cholesterol 0.466 0.445
AHI 0.850 0.882
Metabolic syndrome 0.033 0.047
Log-hsCRP* 0.267 0.107
Log-TBARS* 0.014 0.039
Log-adiponectin* 0.503 0.928
Significant level was set at p value < 0.05 (bold type). Abbreviation was
shown as in Table 1 *log-transformed. Model 1: non-adjusted simple logistic
analysis, Model 2: age-adjusted simple logistic analysis
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Figure 1 Comparisons of the prevalence of CAD, AHI and
circulating levels of adiponectin and TBARS between SDB/OSA
subjects without and with the metabolic sydnrome. CAD,
coronary artery disease; AHI, apnea-hypopnea index; SDB, sleep-
disordered breathing; OSA, obstructive sleep apnea; TBARS,
thiobarbituric acid reactive substance. All values were expressed as
mean ± SEM, and compared by the c
2 and Mann- Whitney U-test
in experiments of two groups. In all cases, p values < 0.05 was
considered statistically significant.
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Page 4 of 6subjects with CAD remain to be understood. The pre-
sent study showed that metabolic syndrome predicts
intracoronary stenotic lesions in SDB/OSA subjects. A
cluster of multiple risk factors based on visceral fat
accumulation accelerates atherosclerogenesis, i.e. meta-
bolic syndrome [23]. The co-existence of metabolic syn-
drome and SDB/OSA based on visceral fat
accumulation, i.e. “Syndrome Z”, may represent two
sides of the same coin, given the common pathophysio-
logical processes evident in both conditions, such as
insulin resistance and atherosclerosis [7,15]. Although
adiponectin per se did not correlate with CAD in SDB/
OSA subjects, serum adiponectin levels were lower in
subjects with the metabolic syndrome than those with-
out the metabolic syndrome. Metabolic syndrome was
related with serum levels of adiponectin (p = 0.029), but
n o tw i t hh s C R Pa n dT B A R S( p = 0.850, p =0 . 1 0 2 ,
respectively). The results suggest that the metabolic syn-
drome and hypoadiponectinemia may play a role in the
development of CAD in subjects with SDB/OSA. The
metabolic syndrome and hypoadiponectinemia might be
a target for prevention of potential CAD in SDB/OSA.
Nasal continuous positive ai r w a yp r e s s u r e( C P A P )i s
the “gold standard” treatment of OSA. A recent double-
blind, placebo-controlled, randomized, and crossover
trial reported that 3 months of nasal CPAP therapy
improved control of elevated blood pressure and a
reduction in metabolic abnormalities including abdom-
inal obesity [24]. Nasal CPAP also reduces the risk of
fatal and non-fatal cardiovascular outcomes [25]. How-
ever, whether visceral fat reduction prevents cardiovas-
cular events in SDB/OSA subjects remains unclear.
Longer observational and interventional trials should be
conducted to assess the effect of visceral fat reduction
on the incidence of cardiovascular events in SDB/OSA
subjects.
Conclusion
We described that metabolic syndrome was correlated
with intracoronary stenosis detected by MSCT in Japa-
nese SDB/OSA subjects, suggesting that any program
designed to prevent cardiovascular diseases in SDB/OSA
subjects should include continuous evaluation of meta-
bolic syndrome.
Study limitations
The present study has several limitations. First, all
patients in this study were Japanese males and any dif-
ferences from other ethnicities are unknown. Second,
there is bias in single center trials. Finally, based upon
80% power to detect statistically significant correlations
between CAD and the various parameters (p = 0.05;
two-sided, r = 0.5, a =0 . 0 5 ,1 - b =0 . 8 ) ,as a m p l es i z eo f
at least 38 patients was required to demonstrate. The
number of patients may be still small, and further inves-
tigations might be required to confirm the present
results.
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